---
schema_version: "secwatch.filing_event.v1"
accession: "0001081188-22-000006"
form_type: "8-K"
ticker: "GEGP"
cik: "0001081188"
company_name: "GOLD ENTERPRISE GROUP INC"
filed_at: "2022-08-01T23:59:59+00:00"
generated_at: "2026-06-24T06:17:53.390529+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "medium"
source: SEC EDGAR
---

# Gold Entertainment to issue 100K Series B preferred shares for controlling stake in DEVON Testing

## Summary
- Issued 100,000 Series B Preferred shares as payment to acquire controlling shares of DEVON MEDICAL PRODUCTS, INC.
- Authorized Preferred B shares increased to 500,000; amended articles filed with Florida.
- Agreement effective February 1, 2022; reported on Form 8-K dated July 30, 2022.

## SEC filing metadata
- accession: 0001081188-22-000006
- form_type: 8-K
- ticker: GEGP
- cik: 0001081188
- company_name: GOLD ENTERPRISE GROUP INC
- filed_at: 2022-08-01T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: medium
- sec_items: 1.01, 3.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1081188/000108118822000006/0001081188-22-000006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1081188/000108118822000006/8k_devon2022.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001081188-22-000006
- JSON: https://secwatch.observer/filing/0001081188-22-000006.json
- Plain text: https://secwatch.observer/filing/0001081188-22-000006.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.